Literature DB >> 7892077

The changing face of neonatal infection: experience at a regional medical center.

A G Philip1.   

Abstract

The incidence, etiology and timing of neonatal infection were assessed in a regional neonatal intensive care unit from 1983 through 1992. Infection onset was considered as very early (< 24 hours), early (1 to 7 days) or late (8 to 60 days). Case-fatality rates were determined for different weight groups and time periods (1983 to 1987 vs. 1988 to 1992). Overall neonatal sepsis incidence changed very little, but there was a marked decrease in very early onset sepsis in 1988 to 1992 especially in very low birth weight (< 1500 g) infants, possibly attributable to increased use of prenatal antibiotics. There was an accompanying increase in late onset sepsis, primarily nosocomial infection associated with improved survival of tiny infants, most striking after exogenous surfactant became readily available. During 1988 to 1992, because of very few very early-onset cases, very low birth weight infants had overall case fatality rates of about 10%, which were the same as for larger infants. The predominant organism in very early onset infection was Group B Streptococcus (GBS) (27 of 58) and in late onset infection was coagulase-negative staphylococcus (57 of 103). More cases of early onset GBS pneumonia were seen in the last 5 years. Neonatal meningitis was seen rarely during this decade, with only one case documented in the first 24 hours of life.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892077     DOI: 10.1097/00006454-199412000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Mortality from early onset group B streptococcal infection in the United Kingdom.

Authors:  N Embleton; U Wariyar; E Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

Review 2.  Neonatal sepsis: epidemiology and management.

Authors:  Robert S Baltimore
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

3.  Microbial profile of neonatal infection in Coimbatore.

Authors:  M Thomas; B Padmini; G Srimathi; V Sundararajan; B A Raju
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

4.  Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period.

Authors:  P Rauprich; O Möller; G Walter; E Herting; B Robertson
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

5.  Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants.

Authors:  Y K Siu; P C Ng; S C Fung; C H Lee; M Y Wong; T F Fok; K W So; K L Cheung; W Wong; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

6.  The Role of 16S rRNA Gene Sequencing in Confirmation of Suspected Neonatal Sepsis.

Authors:  Somaia El Gawhary; Mervat El-Anany; Reem Hassan; Doaa Ali; El Qassem El Gameel
Journal:  J Trop Pediatr       Date:  2015-10-22       Impact factor: 1.165

Review 7.  New modalities for treating neonatal infection.

Authors:  A R Bedford-Russell
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

8.  Neonatal late-onset bloodstream infection: attributable mortality, excess of length of stay and risk factors.

Authors:  C L Pessoa-Silva; C H Miyasaki; M F de Almeida; B I Kopelman; R L Raggio; S B Wey
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

9.  Network-based analysis of diagnosis progression patterns using claims data.

Authors:  Eugene Jeong; Kyungmin Ko; Seungbin Oh; Hyun Wook Han
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

10.  Preincubation of cervical swabs in lim broth improves performance of ICON rapid test for detection of group B Streptococci.

Authors:  S S Altaie; J Bridges; D Loghmanee; A Lele; K R Kahn
Journal:  Infect Dis Obstet Gynecol       Date:  1996
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.